Background Secondary hyperparathyroidism (SHPT), a manifestation of chronic kidney disease-mineral bone disorder (CKD-MBD), is common in CKD patients and has significant morbidity and mortality. Quality of life (QOL) in SHPT patients is seriously affected by symptoms such as bone pain and skin pruritus. However, studies have focused on operative effects and hypocalcemia rather than the relationships between QOL, bone pain, skin pruritus and depression symptoms.Methods A cross-sectional survey was conducted from January 2017 to December 2019 in a third-class hospital in China. The brief table of the QOL measurement scale (QOL-BREF), a self-designed bone pain and skin pruritus scale and the Self-rating Depression Scale (SDS) were used to estimate QOL, bone pain and skin pruritus, and depression, respectively. Pearson’s correlation, multiple linear regression analysis and structural equation modeling (SEM) were used for analysis.Results Overall, 320 questionnaires were considered valid (98.46% effective response rate). The prevalence of bone pain, skin pruritus and depression was 94.06%, 69.06%, and 77.81%, respectively. Bone pain, skin pruritus and depression were significantly associated with QOL. In SEM, QOL negatively correlated with bone pain (r=-0.509), skin pruritus (r=-0.517) and SDS (r=-0.465). Bone pain significantly (P<0.01) and positively correlated with skin pruritus (r=0.568) and SDS (r=0.450). Skin pruritus significantly (P<0.01) and positively correlated with SDS (r=0.426). In addition, QOL partially mediated the association between bone pain or skin pruritus and depression (mediation proportion of 48.62% or 45.08%).Conclusions SHPT patients have high depression levels and poor QOL due to bone pain and skin pruritus. The effects on depression may be fully mediated by the impact of bone pain or skin pruritus on QOL. Thus, bone pain or skin pruritus could increase depression via the intermediary role of QOL.For clinical front-line medical staff,it can relieve bone pain and skin pruritus through timely operation and psychological intervention, so as to improve patients' quality of life and reduce anxiety.At the same time, we should also pay attention to the high-risk groups.
Background Hypocalcemia is a common complication after total parathyroidectomy(t-ptx) in patients with secondary hyperparathyroidism(SHPT), which endangers the lives of patients, but the amount of intravenous calcium supplementation is very different in each patient.Therefore,We aimed to elop a predictive model of intravenous calcium supplementation needs in patients with SHPT after t-ptx.Methods Data for 550 SHPT patients treated in the Department of Hepatobiliary Surgery of the Northern Theater General Hospital were collected from January 2015 - December 2021, with patient biochemical indices being retrospectively evaluated.Results Sex (t=-1.988, p=0.049), serum ferriti (SF) (t=2.155, p=0.033), alkaline phosphatase (AKP) (t=4.501, p=0.000), free thyroxine (FT4) (t=-3.128, p=0.002) were identified as risk factors associated with the need for postoperative intravenous calcium supplementation. The developed predictve model (intravenous calcium supplementation =1235.561-158.547*gender + 0.141*SF + 0.442*AKP - 494.055*FT4; male: 0, female: 1) was effective and passed the F test (F = 22.034, P = 0.000).Conclusions The developed model can be used to reliably predict the amount of intravenous calcium supplementation required by SHPT patients following t-ptx, providing a clinical basis for an evidence-based calcium supplementation scheme.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.